Clinical Trial Update: Testosterone and Alendronate in Hypogonadal Men [Phase 2]

View source ↗

Summary

Phase 2 trial update on testosterone and alendronate in hypogonadal men with osteopenia; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism
• Osteopenia
• Osteoporosis

Drugs mentioned

• TESTOSTERONE (testosterone)
• alendronate (alendronate)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Hypogonadism, Osteopenia | Phase 2 | Status: TERMINATED | Results posted: 2023-10-12